Banks

Tk 75cr loss looms over UCB as stock investment raises questions

United Commercial Bank (UCB) PLC is on the verge of incurring losses of around Tk 75 crore as one-third of its total share market investment has been on a lone stock that has undergone price manipulation.

In 2021, the bank spent Tk 105 crore to buy shares of Genex Infosys while its total share market investment was Tk 472 crore. The value of the investment has now dropped to Tk 27 crore.

This means the bank is counting Tk 78 crore in unrealised losses for the investment.

IT company Genex Infosys provided 11 percent cash and 2 percent stock dividend in fiscal year 2021-22 and the dividend dropped to 6 percent cash and 4 percent stock in the fiscal year 2022-23.

Considering the cash dividends the bank gained from the company in previous years based on the ownership of the stock, the loss may drop to Tk 75 crore.

Interestingly, the board of directors of the bank had taken the decision to invest in Genex Infosys while its management was silent.

Analysts raised questions about the investment as the performance of the stock was never that significant and they think it could have benefitted manipulators in selling off their shares at the cost of the bank depositors' funds.

The Bangladesh Securities and Exchange Commission has earlier found that one Abul Khayer Hiru and his associates manipulated the price of the stock through serial trading around the middle of 2021.

This had led to the price going up by 69 percent within 15 days. Serial trading is the buying and selling of shares between the same beneficiary accounts in order to impact the share price.

Hiru and his two other associates traded the stock through UCB Stock Brokerage Ltd, the BSEC said in its investigation report.

After getting listed in 2019, Genex Infosys's share price ranged between Tk 50 to Tk 60 and it rose up to Tk 175 in 2021 when it underwent the manipulation.

UCB bought the shares when the price of each was more than Tk 170. Its price again fell to the previous Tk 50 to Tk 60 range within one year.

Yesterday, the stock was traded at Tk 43. It is clear that UCB bought the share when the share price was at its peak.

When the price of a stock reaches an abnormally high level due to manipulation, the manipulators need to dump it fast, said Al-Amin, an associate professor of the Accounting and Information Systems Department of the University of Dhaka.

Institutional investors can work well as a dumping station as general investors cannot buy a large number of shares at a high price, he told The Daily Star last week.

"Here the bank was used for dumping. Some people of the bank may be involved who put pressure for the purchase of the shares to benefit the manipulators," he said.

There are many examples of such cases where banks, NBFIs, and mutual funds were misused in the same way, said Al-Amin.

The bank officials or directors who are engaged in buying the stock are provided benefits through underhand deals for the gains of the manipulators, he said.

Meanwhile, the bank's funds become stuck and it incurs a hit and the stock market loses liquidity, he added.

"It's a nexus," said Al-Amin.

A top official of a leading asset management company, preferring anonymity, said all investment decisions should be based on proper research.

No research can support the purchase of this share at such a high price and volume. "So, it is clear that it was bought to benefit someone," he added.

Profits of Genex Infosys dropped 21 percent year-on-year to Tk 30 crore in the first nine months of the fiscal year 2023-24.

Its earnings per share stood at Tk 2.54 in the July-March period of the fiscal year that ended recently.

Commercial banks are largely funded by depositors' money and thus have a fiduciary responsibility towards them and part of that responsibility involves taking prudent investment decisions and risk management practices, said Asif Khan, president of CFA Society Bangladesh.

"The investment in this case seems very large compared to the total portfolio size and thus raises some questions," he added.

A top official of the bank, preferring anonymity, said the purchase decision was taken by the board of directors and termed a "strategic investment".

Usually, it is the management team of a bank that sends such proposals to its board and then, based on it, the board either approves the proposal or declines it. Here, this banking norm was violated, he added.

Several top officials of the UCB confirmed to The Daily Star that the decision was taken by the board of directors under the influence of Anisuzzaman Chowdhury Rony, a former director of the bank.

Mohammod Monwar Hossain, head of the treasury department of the UCB, did not receive phone calls and a text message from The Daily Star last week for a comment representing the bank's management team.

The Daily Star also tried to contact Rony several times. However, his mobile was found switched off.

Comments

Tk 75cr loss looms over UCB as stock investment raises questions

United Commercial Bank (UCB) PLC is on the verge of incurring losses of around Tk 75 crore as one-third of its total share market investment has been on a lone stock that has undergone price manipulation.

In 2021, the bank spent Tk 105 crore to buy shares of Genex Infosys while its total share market investment was Tk 472 crore. The value of the investment has now dropped to Tk 27 crore.

This means the bank is counting Tk 78 crore in unrealised losses for the investment.

IT company Genex Infosys provided 11 percent cash and 2 percent stock dividend in fiscal year 2021-22 and the dividend dropped to 6 percent cash and 4 percent stock in the fiscal year 2022-23.

Considering the cash dividends the bank gained from the company in previous years based on the ownership of the stock, the loss may drop to Tk 75 crore.

Interestingly, the board of directors of the bank had taken the decision to invest in Genex Infosys while its management was silent.

Analysts raised questions about the investment as the performance of the stock was never that significant and they think it could have benefitted manipulators in selling off their shares at the cost of the bank depositors' funds.

The Bangladesh Securities and Exchange Commission has earlier found that one Abul Khayer Hiru and his associates manipulated the price of the stock through serial trading around the middle of 2021.

This had led to the price going up by 69 percent within 15 days. Serial trading is the buying and selling of shares between the same beneficiary accounts in order to impact the share price.

Hiru and his two other associates traded the stock through UCB Stock Brokerage Ltd, the BSEC said in its investigation report.

After getting listed in 2019, Genex Infosys's share price ranged between Tk 50 to Tk 60 and it rose up to Tk 175 in 2021 when it underwent the manipulation.

UCB bought the shares when the price of each was more than Tk 170. Its price again fell to the previous Tk 50 to Tk 60 range within one year.

Yesterday, the stock was traded at Tk 43. It is clear that UCB bought the share when the share price was at its peak.

When the price of a stock reaches an abnormally high level due to manipulation, the manipulators need to dump it fast, said Al-Amin, an associate professor of the Accounting and Information Systems Department of the University of Dhaka.

Institutional investors can work well as a dumping station as general investors cannot buy a large number of shares at a high price, he told The Daily Star last week.

"Here the bank was used for dumping. Some people of the bank may be involved who put pressure for the purchase of the shares to benefit the manipulators," he said.

There are many examples of such cases where banks, NBFIs, and mutual funds were misused in the same way, said Al-Amin.

The bank officials or directors who are engaged in buying the stock are provided benefits through underhand deals for the gains of the manipulators, he said.

Meanwhile, the bank's funds become stuck and it incurs a hit and the stock market loses liquidity, he added.

"It's a nexus," said Al-Amin.

A top official of a leading asset management company, preferring anonymity, said all investment decisions should be based on proper research.

No research can support the purchase of this share at such a high price and volume. "So, it is clear that it was bought to benefit someone," he added.

Profits of Genex Infosys dropped 21 percent year-on-year to Tk 30 crore in the first nine months of the fiscal year 2023-24.

Its earnings per share stood at Tk 2.54 in the July-March period of the fiscal year that ended recently.

Commercial banks are largely funded by depositors' money and thus have a fiduciary responsibility towards them and part of that responsibility involves taking prudent investment decisions and risk management practices, said Asif Khan, president of CFA Society Bangladesh.

"The investment in this case seems very large compared to the total portfolio size and thus raises some questions," he added.

A top official of the bank, preferring anonymity, said the purchase decision was taken by the board of directors and termed a "strategic investment".

Usually, it is the management team of a bank that sends such proposals to its board and then, based on it, the board either approves the proposal or declines it. Here, this banking norm was violated, he added.

Several top officials of the UCB confirmed to The Daily Star that the decision was taken by the board of directors under the influence of Anisuzzaman Chowdhury Rony, a former director of the bank.

Mohammod Monwar Hossain, head of the treasury department of the UCB, did not receive phone calls and a text message from The Daily Star last week for a comment representing the bank's management team.

The Daily Star also tried to contact Rony several times. However, his mobile was found switched off.

Comments

আমরা রাজনৈতিক দল, ভোটের কথাই তো বলব: তারেক রহমান

তিনি বলেন, কিছু লোক তাদের স্বার্থ হাসিলের জন্য আমাদের সব কষ্টে পানি ঢেলে দিচ্ছে।

১১ ঘণ্টা আগে